AIDS Seminar Series 2025 - 5/12/2025 Raphael Landovitz-what’s new in HIV PrEP

Monday, May 12, 2025, 12:30 PM - 1:30 PM, Webinar

AMA PRA Category 1 Credits™ (1.00 hours), ANCC Nursing Contact Hours (1.00 hours), CME-Designated Participation Credit (1.00 hours)

Second Monday of each month, 12:30 to 1:30 pm.

Objective(s): Discuss at least three evidence-based updates in the care of patients who are diagnosed with HIV.
Location: Webinar

Faculty Disclosures:
Raphael J. Landovitz, MD (Membership on Advisory Committees or Review Panels, Board Membership, etc.-Merck (Any division)|Consulting Fee-ViiV Healthcare|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Redqueen Therapeutics (Relationship has ended) - 11/07/2024)

1. Discuss at least three evidence-based updates in the care of patients who are diagnosed with HIV.

In support of improving patient care, Dartmouth Health is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

American Medical Association (AMA)
Dartmouth Health designates this Live Activity for a maximum of 1.00 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

American Nurses Credentialing Center (ANCC)
Dartmouth Health designates this Live Activity for a maximum of 1.00 ANCC contact hours. 

 

Mitigation of Relevant Financial Relationships

Dartmouth Health adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education.  Any individuals in a position to control the content of a CE activity, including planners, faculty, authors, or others are required to disclose all financial relationships with ineligible companies^.  All relevant financial relationships have been mitigated prior to the commencement of the activity.

^Ineligible Company is any entity whose primary business purpose is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients.

Date	Empty Column	Title
5/12/2025 12:30:00 PM	AIDS Seminar Series 2025 - 5/12/2025 Raphael Landovitz-what’s new in HIV PrEP 5/12/2025 12:30:00 PM 5/12/2025 1:30:00 PM 15 Webinar False MM/DD/YYYY	AIDS Seminar Series 2025 - 5/12/2025 Raphael Landovitz-what’s new in HIV PrEP Second Monday of each month, 12:30 to 1:30 pm. Objective(s): Discuss at least three evidence-based updates in the care of patients who are diagnosed with HIV. Location: Webinar Faculty Disclosures: Raphael J. Landovitz, MD (Membership on Advisory Committees or Review Panels, Board Membership, etc.-Merck (Any division)|Consulting Fee-ViiV Healthcare|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Redqueen Therapeutics (Relationship has ended) - 11/07/2024) Location: Webinar